Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and <i>Helicobacter pylori</i> antibody titerTakeichi Yoshida, Masao Ichinose, Shotaro Enomoto et al.|International Journal of Cancer|2013Cited by 178
Eradication of <i>Helicobacter pylori</i> prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levelsKimihiko Yanaoka, Masao Ichinose, Masashi Oka et al.|International Journal of Cancer|2009Cited by 136
Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and <i>Helicobacter pylori</i> antibody together with endoscopic rugal hyperplastic gastritisMika Watanabe, Masao Ichinose, Jun Kato et al.|International Journal of Cancer|2012Cited by 107
Elevated risk of colorectal adenoma with <i>Helicobacter pylori</i>‐related chronic gastritis: A population‐based case‐control studyIzumi Inoue, Masao Ichinose, Chizu Mukoubayashi et al.|International Journal of Cancer|2011Cited by 66